financetom
Business
financetom
/
Business
/
South Indian Bank seeing traction in large corporates, retail; expects slippages to remain elevated
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
South Indian Bank seeing traction in large corporates, retail; expects slippages to remain elevated
Oct 22, 2021 3:45 AM

Private sector South Indian Bank (SIB) on Thursday reported a net loss of Rs 187 crore for the September quarter, hit by higher bad loans. The Kerala-based lender had posted a net profit of Rs 65.10 crore in the same period a year ago. Sequentially, there was a net profit of Rs 10.31 crore in the first quarter ended June of this fiscal. Total income during the July-September quarter of 2021-22 also dropped to Rs 1,746.03 crore from Rs 2,115.71 crore in the same period of the previous fiscal, South Indian Bank said in a regulatory filing. Interest income too was lower at Rs 1,646.59 crore during the quarter from Rs 1,898.84 crore in the year-ago period. On the asset quality front, the gross non-performing assets (NPAs or bad loans) stood at 6.65 percent of the gross advances at the end of the quarter, as against 4.87 percent by September-end 2020. In an interview with CNBC-TV18, Murali Ramakrishnan, MD and CEO of the bank, shed light on the recent Q2 performance and outlook.

Read Here: Morgan Stanley raises target price on BoB, SBI, Canara Bank; here’s why

He said, “The loss is primarily due to additional provisioning of Rs 160 crore, which we have taken on a conservative basis in order to beef up our provision coverage ratio (PCR), or else our loss would have been very low at about Rs 27 crore.”

He added, “We are going through one of the most unprecedented times, market is clearly having a lot of headwinds and we are seeing the impact of COVID, particularly in the retail and SME sector. We are actually seeing good traction happening in large corporates and all our incremental addition is happening with a good quality portfolio. We saw very good traction happening in retail starting from the month of September and SME has also started showing uptick from the last month itself.”

“So by and large, I feel that all the areas which we have taken on for our growth, we are seeing substantial progress happening whether it is CASA, whether it is capital adequacy or PCR or net NPA,” Ramakrishnan said.

Read Here: Unity Small Finance Bank will focus on low ticket size transaction credit: BharatPe’s Ashneer Grover

On advances, he said, “I am really not unduly worried about the degrowth in advances book, it was a conscious effort. If look at the September advances book in comparison with the June ended advances book, we have almost reached similar level and we are just down by some 10 crore which is actually nothing. With the traction which you are seeing in September, it is expected to go up. Again, I would want to clearly say that it is not growth for the sake of growth, we would want to grow the book with good quality so that we don't again have the problem of quality hitting the bank.”

On slippages, Ramakrishnan said, “With the collection team now in place, with recovery now being in full force, we expect things to become better as we go along. But slippages are expected to happen because COVID has completely changed the business model. So, we expect the slippage to be in line with what we have articulated.”

On NIMs, he said, “On the asset side, our NIMs are more or less holding, despite the market rates being very low and pre-emptive pricing is happening both in retail as well as in SME. Our NIMs have gone down only because of the treasury in the past quarter. Actually, we sort of look for the opportunity to make some gains on our exchange portfolio. Because of that, we saw good income arising out of treasury gains, obviously that opportunity was not there in Q2, therefore, there is a dip in terms of NIMs from the treasury. But if you look at the asset side, advances side, it is more or less holding.”

For full management commentary, watch the video.

-With PTI inputs

Also Read: Use festive season demand to drive credit outreach program, Finance Ministry to banks

(Edited by : Dipikka Ghosh)

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Intuitive Surgical Unusual Options Activity For March 18
Intuitive Surgical Unusual Options Activity For March 18
Mar 18, 2024
Deep-pocketed investors have adopted a bearish approach towards Intuitive Surgical ( ISRG ) , and it's something market players shouldn't ignore. Our tracking of public options records at Benzinga unveiled this significant move today. The identity of these investors remains unknown, but such a substantial move in ISRG usually suggests something big is about to happen. We gleaned this information...
US insurers to expedite payments to healthcare providers after hack
US insurers to expedite payments to healthcare providers after hack
Mar 18, 2024
WASHINGTON, March 18 (Reuters) - Health insurers told the U.S. government they would accelerate payments to some healthcare providers indirectly affected by a cyberattack on UnitedHealth Group's ( UNH ) technology unit Change Healthcare, senior U.S. health officials said on Monday. Change Healthcare, which was hit by a cyberattack on Feb. 21, processes about 50% of medical insurance claims in...
Correction: --Street Color: Alibaba Reportedly Appoints Yan Xiaolei CEO of Freshippo
Correction: --Street Color: Alibaba Reportedly Appoints Yan Xiaolei CEO of Freshippo
Mar 18, 2024
03:39 PM EDT, 03/18/2024 (MT Newswires) -- (Corrected with the correct title in the headline.) (Street Color news is derived from real time discussions with market professionals globally subscribed to the Street Color Premium Chat service on Bloomberg IB Chat and the ICE IM. This information is believed to be from reliable sources but may include rumor and speculation. Accuracy...
US approves first gene therapy for children with rare genetic disease
US approves first gene therapy for children with rare genetic disease
Mar 18, 2024
March 18 (Reuters) - The U.S. health regulator on Monday approved UK-based Orchard Therapeutics' gene therapy to treat children with metachromatic leukodystrophy (MLD), making it the first approved treatment in the United States for the rare, hereditary disease. Orchard, which was acquired by Japanese pharmaceutical firm Kyowa Kirin ( KYKOF ) for $477.6 million last year, said it will provide...
Copyright 2023-2026 - www.financetom.com All Rights Reserved